Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($1.17), $0.01 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• UK’s EG Group reportedly files for US IPO worth about $1 billion
• Wealthfront launches custodial account with tax-gain harvesting